Business and Finance Business and Finance
Sun, February 23, 2025
[ Today @ 10:41 AM ] - MSN
"Stop wasting cash": Shark Tank investor Kevin O' .. ares the advice he would give to his younger self
[ Today @ 10:41 AM ] - MSN
In auto-centric Michigan, Trump's proposed tariffs polarize a community
[ Today @ 10:41 AM ] - MSN
Abu Dhabi signs groundbreaking agreements with China to strengthen economic, business partnerships
[ Today @ 10:40 AM ] - AOL
Warren Buffett: America's businesses 'usually find a way'
[ Today @ 10:01 AM ] - MSN
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Today @ 09:41 AM ] - MSN
Top global stories this week: HSBC, Alibaba, Airbus among notable names
[ Today @ 09:20 AM ] - Kiplinger
Investing in Art: 10 Things You Should Know
[ Today @ 08:20 AM ] - GeekWire
Qualterra raises $4.5M to turn organic waste into carbon-trapping, crop-boosting biochar
[ Today @ 08:20 AM ] - MSN
Atmus Filtration Technologies Inc. (NYSE:ATMU) Q4 2024 Earnings Call Transcript
[ Today @ 07:20 AM ] - MSN
What happens when a company's 'low performers' speak up
[ Today @ 07:00 AM ] - Newsday
Keeping a bank account: A fearful, challenging process for some on Long Island
[ Today @ 07:00 AM ] - Tuko
Can Kenyans Buy Bread with Crypto? Experts Weigh in on Cryptocurrency Adoption and Everyday Use
[ Today @ 06:40 AM ] - MSN
What Brand Is Behind Costco's Kirkland Signature Frozen Lasagna?
[ Today @ 06:21 AM ] - MSN
Got $5,000? 2 Top Growth Stocks to Buy That Could Double Your Money.
[ Today @ 04:40 AM ] - MSN
2 cities tried basic income for formerly incarcer .. ore food secure but struggled to pay for housing.
[ Today @ 04:20 AM ] - businessday
Top 10 African countries with high sovereign wealth funds
[ Today @ 03:41 AM ] - Tuko
Well-off Hong Kong daunted by record deficits
[ Today @ 03:40 AM ] - Forbes
Why Personal Finance Pressures Can Affect Founder Exit Decisions
[ Today @ 01:20 AM ] - MSN
Hong Kong and Singapore lead Asia's drive to cash in on crypto boom
[ Today @ 12:40 AM ] - MSN
St. Paul Brewing worries city's new development plan will mean the end to their business
[ Today @ 12:21 AM ] - Variety
Warren Buffett Says 'It Won't Be Long' Before Greg Abel Succeeds Him as Berkshire Hathaway CEO
[ Today @ 12:20 AM ] - MSN
German elections: The leaders to watch
Sat, February 22, 2025
[ Yesterday Evening ] - MSN
Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Yesterday Evening ] - MSN
Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
[ Yesterday Evening ] - AOL
1099-K tax rules: What you need to know if you get paid via Venmo, Cash App or PayPal
[ Yesterday Evening ] - MSN
Trump's IRS layoffs have some Americans asking: 'Why bother' filing taxes this year?
[ Yesterday Evening ] - MSN
Is TriNet Group Inc. (TNET) The Best 52-Week Low Stock To Buy Now According to Short Sellers?
[ Yesterday Evening ] - MSN
Olympic Steel, Inc. (NASDAQ:ZEUS) Q4 2024 Earnings Call Transcript
[ Yesterday Evening ] - ESPN
NBL's Tasmania JackJumpers finally have a new owner
[ Yesterday Evening ] - MSN
Ocugen to Announce Q4 and Full-Year 2024 Results with Live Webcast on March 5, 2025

Amgen Inc. (AMGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts


Published on 2025-02-22 23:41:17 - MSN
  Print publication without navigation

  • We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharmaceutical stocks.

The article from MSN Money discusses Amgen Inc. (AMGN) as one of the undervalued pharmaceutical stocks recommended for investment by analysts. Amgen, known for its biopharmaceutical products, has been highlighted due to its robust pipeline and potential for growth despite recent market fluctuations. The stock is currently trading at a price-to-earnings ratio that suggests it might be undervalued compared to its peers. Analysts point out that Amgen's focus on innovative treatments for serious illnesses, along with its strategic acquisitions, positions it well for future revenue growth. The article also mentions that despite some concerns over patent cliffs and competition, the overall sentiment leans towards optimism, with several analysts upgrading their ratings and setting price targets that suggest significant upside potential. This makes Amgen an attractive option for investors looking for value in the pharmaceutical sector.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/general/amgen-inc-amgn-among-the-cheap-pharmaceutical-stocks-to-buy-according-to-analysts/ar-AA1zB2cG ]
Contributing Sources